CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Helicoll +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01716169
NCT01716169N/ACompleted
CompareCT.gov

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Stanford University·interventional·Posted Oct 29, 2012·Updated May 5, 2016

In Brief

A clinical study evaluating Helicoll and Standard of Care Dressings for Epidermolysis Bullosa Dystrophica and Epidermolysis Bullosa. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to test the effectiveness of Helicoll (a collagen wound dressing) in treating chronic and non-chronic wounds of recessive dystrophic epidermolysis bullosa (RDEB) patients. Helicoll will be compared to standard wound dressings.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpidermolysis Bullosa Dystrophica, Epidermolysis Bullosa
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 29, 2012
Enrollment StartOct 1, 2012
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 13.7 years ago

Interventions

Helicolldevice

Helicoll Collagen I Wound Dressing

Standard of Care Dressingsdevice

Standard of Care wound dressings (e.g. Vaseline gauze)